Kestra Medical Technologies, Ltd. Common Stock
Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company's develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, thera… Read more
Kestra Medical Technologies, Ltd. Common Stock (KMTS) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of October 2025: -0.112x
Based on the latest financial reports, Kestra Medical Technologies, Ltd. Common Stock (KMTS) has a cash flow conversion efficiency ratio of -0.112x as of October 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-18.34 Million) by net assets ($164.08 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Kestra Medical Technologies, Ltd. Common Stock - Cash Flow Conversion Efficiency Trend (2020–2025)
This chart illustrates how Kestra Medical Technologies, Ltd. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Kestra Medical Technologies, Ltd. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Kestra Medical Technologies, Ltd. Common Stock ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Zhejiang Wansheng Co Ltd
SHG:603010
|
0.039x |
|
AMALGAMATED FIN. DL-01
F:A0B0
|
N/A |
|
Peakstone Realty Trust
NYSE:PKST
|
0.037x |
|
Fujian Furi Electronics Co Ltd
SHG:600203
|
-0.035x |
|
Linea Directa Aseguradora SA Compania de Seguros y Reaseguros
MC:LDA
|
0.278x |
|
Gunze Limited
F:GUN
|
-0.009x |
|
Marcopolo S.A
SA:POMO3
|
0.205x |
|
Feng Hsin Steel Co Ltd
TW:2015
|
0.051x |
Annual Cash Flow Conversion Efficiency for Kestra Medical Technologies, Ltd. Common Stock (2020–2025)
The table below shows the annual cash flow conversion efficiency of Kestra Medical Technologies, Ltd. Common Stock from 2020 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-04-30 | $205.41 Million | $-77.61 Million | -0.378x | -209.52% |
| 2024-04-30 | $-209.38 Million | $-72.23 Million | 0.345x | -41.75% |
| 2023-04-30 | $-117.58 Million | $-69.64 Million | 0.592x | +103.50% |
| 2021-04-30 | $1.77 Million | $-29.89 Million | -16.928x | -115.53% |
| 2020-04-30 | $3.86 Million | $-30.29 Million | -7.854x | -- |